Up-Regulation of microRNA-126 May Contribute to Pathogenesis of Ulcerative Colitis via Regulating NF-kappaB Inhibitor IκBα

PLoS ONE

Volumn 7, Issue 12, 2012, Pages

  Feng, Xiao ^a   Wang, Hao ^a   Ye, Shicai ^a   Guan, Jiaxi ^a   Tan, Wenkai ^a   Cheng, Si ^a   Wei, Guoli ^a   Wu, Weiyun ^a   Wu, Feng ^b   Zhou, Yu ^a  

^a GUANGDONG MEDICAL UNIVERSITY   (China)

^b UNIVERSITY OF CHICAGO   (United States)

Author keywords

[No Author keywords available]

Indexed keywords

I KAPPA B ALPHA; MICRORNA 126; MICRORNA 21; MICRORNA 375; ONCOPROTEIN; POLO LIKE KINASE 2;

3' UNTRANSLATED REGION; ADULT; AGED; ARTICLE; COLON BIOPSY; CONTROLLED STUDY; FEMALE; GENE EXPRESSION REGULATION; GENETIC TRANSFECTION; HUMAN; HUMAN TISSUE; IMMUNOFLUORESCENCE; IRRITABLE COLON; MAJOR CLINICAL STUDY; MALE; PATHOGENESIS; PROTEIN EXPRESSION; REVERSE TRANSCRIPTION POLYMERASE CHAIN REACTION; RNA ISOLATION; ULCERATIVE COLITIS; UPREGULATION; WESTERN BLOTTING;

3' UNTRANSLATED REGIONS; ADOLESCENT; ADULT; AGED; AGED, 80 AND OVER; BASE SEQUENCE; CELL LINE; COLITIS, ULCERATIVE; FEMALE; GENE EXPRESSION; GENE EXPRESSION REGULATION; HUMANS; I-KAPPA B PROTEINS; MALE; MICRORNAS; MIDDLE AGED; PROTEIN TRANSPORT; RNA INTERFERENCE; RNA, MESSENGER; YOUNG ADULT;

EID: 84871695308     PISSN: None     EISSN: 19326203     Source Type: Journal    
DOI: 10.1371/journal.pone.0052782     Document Type: Article

References (44)

1. Jiang XL, Cui HF, (2002) An analysis of 10218 ulcerative colitis cases in China. World J Gastroenterol 8: 158-161.
2. Hugot JP, Chamaillard M, Zouali H, Lesage S, Cézard JP, et al. (2001) Association of NOD2 leucine-rich repeat variants with susceptibility to Crohn's disease. Nature 411: 599-603.
3. Ogura Y, Bonen DK, Inohara N, Nicolae DL, Chen FF, et al. (2001) A frameshift mutation in NOD2 associated with susceptibility to Crohn's disease. Nature 411: 603-606.
4. Barrett JC, Hansoul S, Nicolae DL, Cho JH, Duerr RH, et al. (2008) Genome-wide association defines more than 30 distinct susceptibility loci for Crohn's disease. Nat Genet 40: 955-962.
5. McGovern DP, Gardet A, Törkvist L, Goyette P, Essers J, et al. (2010) Genome-wide association identifies multiple ulcerative colitis susceptibility loci. Nat Genet 42: 332-337.
6. Lawrance IC, Fiocchi C, Chakravarti S, (2001) Ulcerative colitis and Crohn's disease: distinctive gene expression profiles and novel susceptibility candidate genes. Hum Mol Genet 10: 445-456.
7. Costello CM, Mah N, Häsler R, Rosenstiel P, Waetzig GH, et al. (2005) Dissection of the inflammatory bowel disease transcriptome using genome-wide cDNA microarrays. PLoS Med 2: e199.
8. Wu F, Dassopoulos T, Cope L, Maitra A, Brant SR, et al. (2007) Genome-wide gene expression differences in Crohn's disease and ulcerative colitis from endoscopic pinch biopsies: insights into distinctive pathogenesis. Inflamm Bowel Dis 13: 807-821.
9. Toedter G, Li K, Marano C, Ma K, Sague S, et al. (2011) Gene expression profiling and response signatures associated with differential responses to infliximab treatment in ulcerative colitis. Am J Gastroenterol 106: 1272-1280.
10. Carthew RW, (2006) Gene regulation by microRNAs. Curr Opin Genet Dev 16: 203-208.
11. Bartel DP, (2004) MicroRNAs: genomics, biogenesis, mechanism and function. Cell 116: 281-297.
12. Taganov KD, Boldin MP, Chang KJ, Baltimore D, (2006) NF-kappaB-dependent induction of microRNA miR-146, an inhibitor targeted to signaling proteins of innate immune responses. Proc Natl Acad Sci U S A 103: 12481-12486.
13. Williams AE, Perry MM, Moschos SA, Larner-Svensson HM, Lindsay MA, (2008) Role of miRNA-146a in the regulation of the innate immune response and cancer. Biochem Soc Trans 36: 1211-1215.
14. Lederhuber H, Baer K, Altiok I, Sadeghi K, Herkner KR, et al. (2010) MicroRNA-146: tiny player in neonatal Innate immunity? Neonatology 99: 51-56.
15. Sato T, Liu X, Nelson A, Nakanishi M, Kanaji N, et al. (2010) Reduced miR-146a increases prostaglandin E2 in chronic obstructive pulmonary disease fibroblasts. Am J Respir Crit Care Med 182: 1020-1029.
16. Sonkoly E, Stahle M, Pivarcsi A, (2008) MicroRNAs and immunity: novel players in the regulation of normal immune function and inflammation. Semin Cancer Biol 18: 131-140.
17. Zhou B, Wang S, Mayr C, Bartel DP, Lodish HF, (2007) MiR-150, a microRNA expressed in mature B and T cells, blocks early B cell development when expressed prematurely. Proc Natl Acad Sci U S A 104: 7080-7085.
18. Wu F, Zikusoka M, Trindade A, Dassopoulos T, Harris ML, et al. (2008) MicroRNAs are differentially expressed in ulcerative colitis and alter expression of macrophage inflammatory peptide-2 alpha. Gastroenterology 135: 1624-1635.
19. Takagi T, Naito Y, Mizushima K, Hirata I, Yagi N, et al. (2010) Increased expression of microRNA in the inflamed colonic mucosa of patients with active ulcerative colitis. J Gastroenterol Hepatol 25: S129-133.
20. Fasseu M, Tréton X, Guichard C, Pedruzzi E, Cazals-Hatem D, et al. (2010) Identification of restricted subsets of mature microRNA abnormally expressed in inactive colonic mucosa of patients with inflammatory bowel disease. PLoS One 5: e13160.
21. Wu F, Zhang S, Dassopoulos T, Harris ML, Bayless TM, et al. (2010) Identification of microRNAs associated with ileal and colonic Crohn's disease. Inflamm Bowel Dis 16: 1729-1738.
22. Olaru AV, Selaru FM, Mori Y, Vazquez C, David S, et al. (2011) Dynamic changes in the expression of MicroRNA-31 during inflammatory bowel disease-associated neoplastic transformation. Inflamm Bowel Dis 17: 221-231.
23. Bian Z, Li L, Cui J, Zhang H, Liu Y, et al. (2011) Role of miR-150-targeting c-Myb in colonic epithelial disruption during dextran sulphate sodium-induced murine experimental colitis and human ulcerative colitis. J Pathol 225: 544-553.
24. Wu F, Guo NJ, Tian H, Marohn M, Gearhart S, et al. (2011) Peripheral blood microRNAs distinguish active ulcerative colitis and Crohn's disease. Inflamm Bowel Dis 17: 241-250.
25. Ahmed FE, Jeffries CD, Vos PW, Flake G, Nuovo GJ, et al. (2009) Diagnostic microRNA markers for screening sporadic human colon cancer and active ulcerative colitis in stool and tissue. Cancer Genomics Proteomics 6: 281-295.
26. Wei B, Pei G, (2010) MicroRNAs: critical regulators in Th17 cells and players in diseases. Cell Mol Immunol 7: 175-181.
27. Dalal SR, Kwon JH, (2010) The Role of microRNA in inflammatory bowel disease. Gastroenterol Hepatol (N Y) 6: 714-722.
28. Sutherland LR, Martin F, Greer S, Robinson M, Greenberger N, et al. (1987) 5-Aminosalicylic acid enema in the treatment of distal ulcerative colitis, proctosigmoiditis, and proctitis. Gastroenterology 92: 1894-1898.
29. Shuo Gu, Lan Jin, Feijie Zhang, Sarnow P, Kay MA, (2009) Biological basis for restriction of microRNA targets to the 3′untranslated region in mammalian mRNAs. Nat Struct Mol Biol 16: 144-150.
30. Li Z, Lu J, Sun M, Mi S, Zhang H, et al. (2008) Distinct microRNA expression profiles in acute myeloid leukemia with common translocations. Proc Natl Acad Sci U S A 105: 15535-15540.
31. Feng R, Chen X, Yu Y, Su L, Yu B, et al. (2010) miR-126 functions as a tumour suppressor in human gastric cancer. Cancer Lett 298: 50-63.
32. Li X, Shen Y, Ichikawa H, Antes T, Goldberg GS, (2009) Regulation of miRNA expression by Src and contact normalization: effects on non-anchored cell growth and migration. Oncogene 28: 4272-4283.
33. Crawford M, Brawner E, Batte K, Yu L, Hunter MG, et al. (2008) MicroRNA-126 inhibits invasion in non-small cell lung carcinoma cell lines. Biochem Biophys Res Commun 373: 607-612.
34. Harris TA, Yamakuchi M, Ferlito M, Mendell JT, Lowenstein CJ, (2008) MicroRNA-126 regulates endothelial expression of vascular cell adhesion molecule 1. Proc Natl Acad Sci U S A 105: 1516-1521.
35. Mattes J, Collison A, Plank M, Phipps S, Foster PS, (2009) Antagonism of microRNA-126 suppresses the effector function of TH2 cells and the development of allergic airways disease. Proc Natl Acad Sci U S A 106: 18704-18709.
36. Murakami Y, Yasuda T, Saigo K, Urashima T, Toyoda H, et al. (2006) Comprehensive analysis of microRNA expression patterns in hepatocellular carcinoma and non-tumorous tissues. Oncogene 25: 2537-2545.
37. Visekruna A, Joeris T, Seidel D, Kroesen A, Loddenkemper C, et al. (2006) Proteasome-mediated degradation of IkappaBalpha and processing of p105 in Crohn's disease and ulcerative colitis. J Clin Invest 116: 3195-3203.
38. Tak PP, Firestein GS, (2001) NF- kappa B: a key role in inflammatory diseases. J. Clin. Invest 107: 7-11.
39. Stevens C, Walz G, Singaram C, Lipman ML, Zanker B, et al. (1992) Tumor necrosis factor-alpha, interleukin-1 beta, and interleukin-6 expression in inflammatory bowel disease. Dig Dis Sci 37: 818-826.
40. Szamosi T, Lakatos PL, (2009) Hungarian IBD Study Group, Szilvasi A, Lakatos L, et al (2009) The 3'UTR NFKBIA variant is associated with extensive colitis in Hungarian IBD patients. Dig Dis Sci 54: 351-359.
41. Dijkstra G, Moshage H, Jansen PL (2002) Blockade of NF-kappaB activation and donation of nitric oxide: new treatment options in inflammatory bowel disease? Scand J Gastroenterol Suppl 236: 37-41.
42. Ukil A, Maity S, Das PK, (2006) Protection from experimental colitis by theaflavin-3,3′-digallate correlates with inhibition of IKK and NF-kappaB activation. Br J Pharmacol 149: 121-131.
43. Woronicz JD, Gao X, Cao Z, Rothe M, Goeddel DV, (1997) IkappaB kinase-beta: NF-kappaB activation and complex formation with IkappaB kinase-alpha and NIK. Science 278: 866-869.
44. Mahabeleshwar GH, Kundu GC, (2003) Syk, a protein-tyrosine kinase, suppresses the cell motility and nuclear factor kappa B-mediated secretion of urokinase type plasminogen activator by inhibiting the phosphatidylinositol 3′-kinase activity in breast cancer cells. J Biol Chem 278: 6209-6221.